Epilepsy Incidence Among Children in the United States
ID: 355205Type: Forecasted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355205

Additional Information

https://www.nap.edu/read/13379/chapter/1; https://pubmed.ncbi.nlm.nih.gov/32451250/
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with the condition, and examining disparities in incidence rates across various demographic and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and the application deadline is set for January 23, 2025. Interested applicants can reach out to Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521 for further information.

    Point(s) of Contact
    Alison Amoroso, Scientific Program Official
    (470) 395-2521
    aamoroso@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)." This initiative aims to conduct surveillance of diabetes among youth under 18 years and young adults aged 18 to 44, focusing on estimating diabetes incidence and prevalence across various demographic and geographic factors to identify disparities in diabetes burden. The project will consist of two components: one for direct surveillance and another serving as a Coordinating Center to standardize methodologies and provide statistical expertise. The estimated total program funding is $12.8 million, with an award ceiling of $700,000 for up to six awards. Interested applicants can reach out to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536, with applications due by January 10, 2025, and awards expected to be announced by September 30, 2025.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)." This initiative aims to support investigator-initiated research focused on identifying and evaluating potential risk factors associated with ALS, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The program is significant for advancing understanding of ALS and its risk factors, especially in diverse populations, including racial and ethnic minorities and military veterans. Interested applicants can apply for funding ranging from $0 to $500,000, with an estimated total program funding of $7.5 million available for approximately eight awards. Applications must be submitted electronically by November 4, 2024, and inquiries can be directed to Candis M. Hunter, PhD, MSPH, REHS, at ncipcerpo@cdc.gov.
    Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a funding opportunity titled "Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance" through a cooperative agreement. The primary objective of this initiative is to support jurisdictional EHDI programs in improving data quality and utilization to enhance the screening, diagnosis, and early intervention for infants who are Deaf or Hard of Hearing (D/HH). This funding is crucial for jurisdictions to develop efficient systems for data analysis and integration, ultimately addressing gaps in timely screening and intervention services. The estimated total program funding is $35,200,000, with individual awards ranging from $200,000 to $290,000, and applications are due by March 14, 2025. For further inquiries, interested applicants can contact Deidra Green at deg4@cdc.gov or by phone at 404-498-3034.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement a protocol for managing urinary and kidney systems in young children with myelomeningocele. The program is critical for understanding health outcomes and improving care for this population, with an estimated total funding of $2,330,000, awarding between $166,428 and $488,571 to approximately 19 recipients. Interested small businesses can reach out to Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov for further details, with applications due by April 4, 2025, and project start anticipated in September 2025.
    Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches to Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement for research aimed at rigorously evaluating community- and societal-level primary prevention approaches to prevent Adverse Childhood Experiences (ACEs). The initiative seeks to support investigator-initiated research that assesses existing policies and programs designed to prevent ACEs, particularly those that address social and health inequities affecting vulnerable populations. With an estimated total program funding of $2.7 million and an award ceiling of $450,000, the CDC anticipates awarding two grants under this opportunity, which is open to unrestricted applicants. Interested parties must submit their applications electronically by December 2, 2024, to be considered for funding, and can direct inquiries to Joyce Dieterly at ncipcerpo@cdc.gov.
    Advancing the Centers of Excellence in Newcomer Health
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.